Although no prior research has explored the connection between hyperandrogenism and CDH5 expression, patients with hyperandrogenic PCOS face a notably elevated risk of ovarian hyperstimulation syndrome (OHSS) and exhibit significantly heightened vascular endothelial cell permeability during hyperovulation. The gene discussed is CDH5; the disease is polycystic ovary syndrome.